H-L-Ala-AMC*TFA

H-L-Ala-AMC*TFA is an alanine-based amino acid amide conjugate bearing the AMC fluorophore (7-amino-4-methylcoumarin) and supplied as the corresponding TFA salt. The molecule contains the L-alanine stereocenter, a peptide-like amide linkage to the AMC moiety, and a terminal carboxamide environment that can participate in enzyme-recognition motifs during biochemical assays. The AMC group provides a strong spectroscopic handle for fluorescence readouts, while the TFA counterion supports salt formation and improved handling of the chiral substrate. The compound's combination of a defined amino acid stereochemistry and a fluorogenic reporter makes it a practical research intermediate for quantitative studies of aminopeptidase and related protease substrate specificity, as well as a reagent scaffold for downstream derivatization.

1. Protease Substrate Assays

H-L-Ala-AMC*TFA is used in enzymology and chemical biology workflows to generate fluorescence-based readouts of proteolytic cleavage. The L-alanine residue and the amide bond to the AMC reporter mimic peptide substrate features that proteases can recognize, while the chiral configuration at alanine enables stereochemical specificity testing. The AMC fluorophore enables continuous or endpoint monitoring when the substrate is processed, and the TFA salt form supports consistent reagent solubility in assay-relevant media. The resulting cleavage products can be used to map substrate preferences, compare enzyme variants, and support inhibitor screening campaigns at the biochemical research stage. The alanine-AMC architecture also serves as a reference point for broader amino acid derivatization studies in peptide chemistry.

2. Peptide Coupling Standards

H-L-Ala-AMC*TFA can be applied as a coupling-relevant amino acid derivative for constructing AMC-labeled peptide building blocks in synthetic organic chemistry. The alanine amide motif and the protected salt form provide a defined functional group pattern that can be carried through peptide coupling strategies, including N-acylation and amide bond formation steps that preserve stereochemical integrity. The AMC reporter functions as a downstream analytical tag, allowing coupled products to be tracked by fluorescence after purification or during process development. The compound's structure supports preparation of related fluorogenic substrates for peptide synthesis optimization and method development. The chiral amino acid framework aligns with protected amino acid chemistry principles used to control side reactions during amide-forming transformations.

3. Enzyme Specificity Mapping

H-L-Ala-AMC*TFA is suitable for SAR studies and mechanistic investigations focused on amino acid recognition determinants in enzyme active sites. The L-alanine side chain provides a minimal hydrophobic substituent that can be systematically varied in analog libraries, while the AMC reporter translates cleavage events into quantifiable fluorescence signals. The amide linkage geometry and the stereocenter enable comparisons across stereoisomeric or residue-substituted substrates to evaluate how stereochemistry and backbone electronics influence catalysis. The TFA salt form can be leveraged to standardize reagent handling when preparing panels of amino acid-AMC derivatives. The resulting dataset supports rational selection of amino acid substitutions for further peptide analog construction and biochemical characterization.

4. Fluorogenic Bioconjugation Handles

H-L-Ala-AMC*TFA can function as a fluorescent labeling reagent precursor for designing AMC-tagged biomolecule modification strategies. The presence of a peptide-like alanine amide and a fluorogenic coumarin reporter enables incorporation into larger constructs where enzymatic or chemical cleavage can generate a measurable fluorescence change. The defined stereochemistry of the alanine unit can be retained when AMC-labeled fragments are assembled into peptide conjugates for chemical biology experiments. The TFA counterion supports salt formation that can improve handling during intermediate preparation and coupling steps. Downstream, the compound can be used to generate fluorescence-traceable intermediates that support biomolecule labeling workflows and analytical monitoring of conjugation chemistry.

5. Pharmaceutical Intermediate Research

H-L-Ala-AMC*TFA is applicable to process chemistry intermediate development where fluorogenic amino acid derivatives are used to monitor transformations and validate synthetic routes. The compound's stable amide linkage, alanine stereocenter, and AMC reporter provide a structurally defined reference material for method qualification in fine chemical synthesis contexts. The TFA salt form can be used to standardize material behavior during intermediate handling, including controlled dissolution for analytical sampling and in-process characterization. The amino acid-AMC scaffold can also guide the design of related protected amino acid derivatives that incorporate reporter groups for route scouting and impurity tracking. The structural features align with industrially relevant amino acid chemistry practices that emphasize stereodefined intermediates and reliable analytical traceability.

1. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

2. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

3. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

4. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

5. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle